spironolactone has been researched along with 19-hydroxy-4-androstene-3,17-dione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katahira, K; Kohara, K; Kumahara, Y; Mikami, H; Ogihara, T; Ohde, H | 1 |
| Sekihara, H | 1 |
2 other study(ies) available for spironolactone and 19-hydroxy-4-androstene-3,17-dione
| Article | Year |
|---|---|
Direct vascular effects of 19-hydroxyandrostenedione.
Topics: Aldosterone; Androstenedione; Animals; Desipramine; Dose-Response Relationship, Drug; Ear; Female; Hemodynamics; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Prazosin; Rabbits; Regional Blood Flow; Spironolactone; Vasoconstriction | 1989 |
19-Hydroxyandrostenedione: evidence for a new class of sodium-retaining and hypertensinogenic steroids.
Topics: Aldosterone; Androstenedione; Animals; Blood Pressure; Corticosterone; Desoxycorticosterone; Drug Interactions; Potassium; Rats; Renin; Sodium; Spironolactone | 1983 |